United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $709.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $120.8M | 17.0% |
| Other Investing | $366.1M | 51.6% |
| Working Capital | $66.0M | 9.3% |
| Net Cash Flow | $156.1M | 22.0% |